Abstract:
A protein scaffold based on a consensus sequence of the tenth fibronectin type III (FN3) repeat from human fibronectin, including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG bassed on the consensus sequence have been identified as useful for diagnostic and/or therapeutic applications.
Abstract:
A protein scaffold based on a consensus sequence of fϊbronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fϊbronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG have been identified as useful for diagnostic and/or therapeutic applications.
Abstract:
The invention relates to compositions and methods for generating and using plX phage display libraries for producing non-antibody scaffold protein fusions using plX of M13 phage.
Abstract:
The invention relates to compositions and methods for generating and using plX phage display libraries for producing non-antibody scaffold protein fusions using plX of M13 phage.
Abstract:
A method and apparatus allow for remotely playing back recorded personalized and non-personalized audio messages to a listener. A first recorded message, which has been personalized for an intended listener, is stored in a first memory of an audio player. A second recorded message, which has not been personalized for an intended listener, is stored in a second memory of the audio player. Responsive to receiving a control command from a remote control device, the audio player plays the messages according to a predetermined arrangement, such as in a predetermined order or at predetermined intervals (e.g., the personalized message may be played a number of times before the non-personalized message is played). In one embodiment, the personalized message contains audio intended to be a calming and/or instructional influence on a small child. In another embodiment, the non- personalized message may include information associated with a sponsoring business.
Abstract:
A method and apparatus allow for remotely playing back recorded personalized and non-personalized audio messages to a listener. A first recorded message, which has been personalized for an intended listener, is stored in a first memory of an audio player. A second recorded message, which has not been personalized for an intended listener, is stored in a second memory of the audio player. Responsive to receiving a control command from a remote control device, the audio player plays the messages according to a predetermined arrangement, such as in a predetermined order or at predetermined intervals (e.g., the personalized message may be played a number of times before the non-personalized message is played). In one embodiment, the personalized message contains audio intended to be a calming and/or instructional influence on a small child. In another embodiment, the non- personalized message may include information associated with a sponsoring business.
Abstract:
A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof. The protein scaffold molecules of the present invention exhibit enhanced thermal and chemical stability while presenting six modifiable loop domains which can be engineered to form a binding partner capable of binding to a target for applications in diagnostic and/or therapeutic compositions, methods and devices.
Abstract:
The invention provides methods for testing and ranking therapeutic antibody candidates for biophysical properties related to solubility and the susceptibility of the antibody to aggregate in aqueous solutions. The methods are useful for selecting among antibody libraries or variants for candidates which can be formulated at high concentrations.
Abstract:
In general, in a first aspect, the invention features photonic crystal fibers that include a core (120) extending along a waveguide axis, a confinement region (110) extending along the waveguide axis (199) surrounding the core, and a cladding (160) extending along the waveguide axis surrounding the confinement region, wherein the cladding has an asymmetric cross-section.
Abstract:
In general, in one aspect, the invention features systems, including a photonic crystal fiber (120) including a core (210) extending along a waveguide axis and a dielectric confinement region (220) surrounding the core, the dielectric confinement region (220) being configured to guide radiation along the waveguide axis from an input end to an output end of the photonic crystal fiber (120). The systems also includes a handpiece (680) attached to the photonic crystal fiber (120), wherein the handpiece allows an operator to control the orientation of the output end to direct the radiation to a target location of a patient.